
Read More
Triple-digit CAGR pharma player hits the market: Should you invest?...
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 285 per c...

Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 285 per c...